The agreement signed between Institut Curie and the Institut de Recherche Pierre Fabre will focus on new therapeutic strategies to fight against cancer. According to the two French institutes, the biology of novel therapeutically tractable targets will be deepened, and the impact of innovative pharmacological approaches leveraging the Institut Curie’s biological models will be evaluated.